Intensification of the Company’s international development with the appointment of a new CEO 

Read

Sensorion reports full year 2016 results in line with status of clinical development

Read

Sensorion receives European authorization to initiate Phase II clinical trial of SENS-111 to treat acute vertigo

Read

2017 Financial Calendar

Read

Sensorion Inner Ear Disease Product Candidates and Technology Subject of Multiple Presentations at ARO MidWinter Meeting 2017

Read

Pipeline

2018 08 Pipeline

Enregistrer

Patient center

Corporate presentation

Next events